David M Denton
Insider
First SEC filing: April 5, 2022 · Latest: April 5, 2022
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 1, 2026 | NKE | A | 71,234 | · | · | 71,234 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2026 | NKE | A | 259,946 | · | · | 259,946 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 3, 2026 | HONA | A | 572 | · | · | 572 Direct | · | Acquired | (price as of 2026-10-02) |
| June 29, 2026 | HONA | A | 135 | $226.24 | $30,542 | 135 Direct | · | Acquired | -31.7% (price as of 2026-10-02) |
| March 3, 2026 | PFE | A | 216,537 | · | · | 216,537 Direct | · | Acquired | (price as of 2026-10-02) |
| March 4, 2025 | PFE | A | 413,138 | · | · | 413,138 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 12, 2024 | PFE | D | 103,320 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 12, 2024 | PFE | A | 103,320 | · | · | 103,320 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 12, 2024 | PFE | D | 80,703 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 12, 2024 | PFE | A | 80,703 | · | · | 80,703 Direct | · | Acquired | (price as of 2026-10-02) |
| May 31, 2024 | PFE | F | 12,107 | $28.66 | $346,987 | 37,919 Direct | -24.20% | Disposed | -3.0% (price as of 2026-10-02) |
| Feb. 27, 2024 | PFE | A | 161,160 | · | · | 161,160 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 27, 2024 | PFE | A | 142,400 | · | · | 142,400 Direct | · | Acquired | (price as of 2026-10-02) |
| May 31, 2023 | PFE | F | 16,223 | $38.02 | $616,798 | 48,224 Direct | -25.17% | Disposed | -26.9% (price as of 2026-10-02) |
| Feb. 23, 2023 | PFE | A | 103,320 | · | · | 103,320 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 23, 2023 | PFE | A | 89,920 | · | · | 89,920 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 15, 2022 | TPR | A | 2,430 | $34.98 | $85,001 | 37,647 Direct | +6.90% | Acquired | 237.7% (price as of 2026-10-02) |
| Nov. 15, 2022 | TPR | A | 6,822 | · | · | 6,822 Direct | · | Acquired | (price as of 2026-10-02) |
| May 31, 2022 | PFE | A | 61,275 | · | · | 62,165 Direct | +6884.83% | Acquired | (price as of 2026-10-02) |
| May 31, 2022 | PFE | A | 80,703 | · | · | 80,703 Direct | · | Acquired | (price as of 2026-10-02) |
| May 31, 2022 | PFE | A | 70,313 | · | · | 70,313 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2022 | LOW | A | 18,265 | · | · | 18,265 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2022 | LOW | M | 38,220 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 1, 2022 | LOW | A | 5,350 | · | · | 56,663 Direct | +10.43% | Acquired | (price as of 2026-10-02) |
| April 1, 2022 | LOW | F | 21,230 | $202.40 | $4,296,952 | 51,313 Direct | -29.27% | Disposed | -10.7% (price as of 2026-10-02) |
| April 1, 2022 | LOW | M | 38,220 | · | · | 72,543 Direct | +111.35% | Acquired | (price as of 2026-10-02) |
| March 17, 2022 | LOW | A | 38,220 | · | · | 38,220 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2022 | LOW | F | 3,737 | $258.48 | $965,940 | 34,323 Direct | -9.82% | Disposed | -30.1% (price as of 2026-10-02) |
| Nov. 3, 2021 | TPR | A | 1,793 | $41.82 | $74,983 | 35,162 Direct | +5.37% | Acquired | 182.4% (price as of 2026-10-02) |
| Nov. 3, 2021 | TPR | A | 5,523 | · | · | 5,523 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2021 | LOW | A | 21,593 | · | · | 21,593 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2021 | LOW | A | 5,660 | · | · | 38,060 Direct | +17.47% | Acquired | (price as of 2026-10-02) |
| Nov. 5, 2020 | TPR | A | 3,035 | $24.71 | $74,995 | 33,350 Direct | +10.01% | Acquired | 378.0% (price as of 2026-10-02) |
| Nov. 5, 2020 | TPR | A | 7,282 | · | · | 7,282 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2020 | LOW | A | 57,141 | · | · | 57,141 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2020 | LOW | A | 13,200 | · | · | 32,400 Direct | +68.75% | Acquired | (price as of 2026-10-02) |
| Nov. 7, 2019 | TPR | A | 2,771 | $27.07 | $75,011 | 30,210 Direct | +10.10% | Acquired | 336.4% (price as of 2026-10-02) |
| Nov. 7, 2019 | TPR | A | 13,069 | · | · | 13,069 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2019 | LOW | A | 41,900 | · | · | 41,900 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2019 | LOW | A | 9,550 | · | · | 19,200 Direct | +98.96% | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2019 | LOW | A | 40,700 | · | · | 40,700 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 2, 2019 | LOW | A | 9,650 | · | · | 9,650 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 29, 2018 | CVS | S | 25,159 | $80.13 | $2,015,991 | 403 Direct | -98.42% | Disposed | 7.9% (price as of 2026-10-02) |
| Nov. 8, 2018 | TPR | A | 1,743 | $43.03 | $75,001 | 27,361 Direct | +6.80% | Acquired | 174.5% (price as of 2026-10-02) |
| Nov. 8, 2018 | TPR | A | 7,712 | · | · | 7,712 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2018 | CVS | A | 116,767 | $62.21 | $7,264,075 | 116,767 Direct | · | Acquired | 39.0% (price as of 2026-10-02) |
| April 1, 2018 | CVS | F | 4,351 | $62.21 | $270,676 | 25,495 Direct | -14.58% | Disposed | 39.0% (price as of 2026-10-02) |
| Feb. 28, 2018 | CVS | J | 1,851 | $67.73 | $125,368 | 20,252 Direct | -8.37% | Disposed | 27.7% (price as of 2026-10-02) |
| Feb. 28, 2018 | CVS | F | 1,613 | $67.73 | $109,248 | 22,103 Direct | -6.80% | Disposed | 27.7% (price as of 2026-10-02) |
| Feb. 28, 2018 | CVS | A | 5,315 | $67.73 | $359,985 | 23,716 Direct | +28.88% | Acquired | 27.7% (price as of 2026-10-02) |
| Feb. 20, 2018 | CVS | J | 18,057 | · | · | 18,401 Direct | -49.53% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2018 | CVS | J | 10,869 | · | · | 89,310 Direct | -10.85% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2018 | CVS | J | 22,716 | · | · | 48,980 Direct | -31.68% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2018 | CVS | J | 25,540 | · | · | 34,382 Direct | -42.62% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2018 | CVS | J | 30,325 | · | · | 32,618 Direct | -48.18% | Disposed | (price as of 2026-10-02) |
| Feb. 20, 2018 | CVS | J | 38,836 | · | · | 114,041 Direct | -25.40% | Disposed | (price as of 2026-10-02) |
| Nov. 9, 2017 | TPR | A | 1,868 | $40.16 | $75,019 | 25,564 Direct | +7.88% | Acquired | 194.1% (price as of 2026-10-02) |
| Nov. 9, 2017 | TPR | A | 9,338 | · | · | 9,338 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 11, 2017 | CVS | M | 108,183 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 108,183 | $79.62 | $8,613,530 | 36,056 Direct | -75.00% | Disposed | 8.6% (price as of 2026-10-02) |
| Sept. 11, 2017 | CVS | M | 108,183 | $54.53 | $5,899,219 | 144,239 Direct | +300.04% | Acquired | 58.6% (price as of 2026-10-02) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 105,040 | $79.68 | $8,369,587 | 36,056 Direct | -74.45% | Disposed | 8.5% (price as of 2026-10-02) |
| Sept. 11, 2017 | CVS | S 10b5-1 | 23,855 | $79.61 | $1,899,097 | 141,096 Direct | -14.46% | Disposed | 8.6% (price as of 2026-10-02) |
| June 12, 2017 | CVS | M | 107,178 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 12, 2017 | CVS | M | 110,912 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 12, 2017 | CVS | M | 12,420 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 12, 2017 | CVS | S 10b5-1 | 230,510 | $80.00 | $18,440,800 | 164,563 Direct | -58.35% | Disposed | 8.1% (price as of 2026-10-02) |
| June 12, 2017 | CVS | M | 107,178 | $34.96 | $3,746,943 | 395,073 Direct | +37.23% | Acquired | 147.3% (price as of 2026-10-02) |
| June 12, 2017 | CVS | M | 110,912 | $45.07 | $4,998,804 | 287,895 Direct | +62.67% | Acquired | 91.8% (price as of 2026-10-02) |
| June 12, 2017 | CVS | M | 12,420 | $40.28 | $500,278 | 176,983 Direct | +7.55% | Acquired | 114.6% (price as of 2026-10-02) |
| April 3, 2017 | CVS | A | 100,179 | $78.05 | $7,818,971 | 100,179 Direct | · | Acquired | 10.8% (price as of 2026-10-02) |
| April 3, 2017 | CVS | A | 12,812 | $78.05 | $999,977 | 152,877 Direct | +9.15% | Acquired | 10.8% (price as of 2026-10-02) |
| April 2, 2017 | CVS | F | 6,649 | $78.50 | $521,946 | 164,563 Direct | -3.88% | Disposed | 10.1% (price as of 2026-10-02) |
| April 1, 2017 | CVS | F | 2,420 | $78.50 | $189,970 | 171,212 Direct | -1.39% | Disposed | 10.1% (price as of 2026-10-02) |
| March 10, 2017 | CVS | M | 95,618 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 10, 2017 | CVS | S 10b5-1 | 95,618 | $80.68 | $7,714,460 | 154,717 Direct | -38.20% | Disposed | 7.2% (price as of 2026-10-02) |
| March 10, 2017 | CVS | M | 95,618 | $36.23 | $3,464,240 | 250,335 Direct | +61.80% | Acquired | 138.6% (price as of 2026-10-02) |
| Feb. 28, 2017 | CVS | A | 18,615 | $80.58 | $1,499,997 | 162,223 Direct | +12.96% | Acquired | 7.3% (price as of 2026-10-02) |
| Feb. 28, 2017 | CVS | F | 7,506 | $80.58 | $604,833 | 154,717 Direct | -4.63% | Disposed | 7.3% (price as of 2026-10-02) |
| Nov. 10, 2016 | TPR | A | 11,284 | · | · | 11,284 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 10, 2016 | TPR | A | 2,042 | $36.72 | $74,982 | 23,628 Direct | +9.46% | Acquired | 221.7% (price as of 2026-10-02) |
| April 1, 2016 | CVS | A | 71,696 | $104.82 | $7,515,175 | 71,696 Direct | · | Acquired | -17.5% (price as of 2026-10-02) |
| April 1, 2016 | CVS | A | 9,540 | $104.82 | $999,983 | 158,980 Direct | +6.38% | Acquired | -17.5% (price as of 2026-10-02) |
| April 1, 2016 | CVS | F | 12,902 | $104.82 | $1,352,388 | 143,266 Direct | -8.26% | Disposed | -17.5% (price as of 2026-10-02) |
| Feb. 29, 2016 | CVS | A | 16,748 | $97.17 | $1,627,403 | 129,257 Direct | +14.89% | Acquired | -11.0% (price as of 2026-10-02) |
| Dec. 28, 2015 | TPR | A | 24 | $32.72 | $785 | 21,524 Direct | +0.11% | Acquired | 261.0% (price as of 2026-10-02) |
| Nov. 4, 2015 | TPR | A | 11,734 | $32.28 | $378,774 | 11,734 Direct | · | Acquired | 265.9% (price as of 2026-10-02) |
| Nov. 4, 2015 | TPR | M | 2,330 | · | · | 2,323 Direct | -50.08% | Disposed | (price as of 2026-10-02) |
| Nov. 4, 2015 | TPR | A | 2,323 | · | · | 4,565 Direct | +103.61% | Acquired | (price as of 2026-10-02) |
| Nov. 4, 2015 | TPR | A | 2,330 | · | · | 19,177 Direct | +13.83% | Acquired | (price as of 2026-10-02) |
| Sept. 28, 2015 | TPR | A | 28 | $28.01 | $784 | 88 Direct | +46.67% | Acquired | 321.7% (price as of 2026-10-02) |
| June 29, 2015 | TPR | A | 22 | $35.46 | $780 | 60 Direct | +57.89% | Acquired | 233.1% (price as of 2026-10-02) |
| May 9, 2015 | TPR | M | 1,847 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 9, 2015 | TPR | M | 1,847 | · | · | 16,847 Direct | +12.31% | Acquired | (price as of 2026-10-02) |
| April 2, 2015 | CVS | F | 6,648 | $102.71 | $682,816 | 112,187 Direct | -5.59% | Disposed | -15.8% (price as of 2026-10-02) |
| April 1, 2015 | CVS | A | 59,922 | $102.26 | $6,127,624 | 59,922 Direct | · | Acquired | -15.5% (price as of 2026-10-02) |
| April 1, 2015 | CVS | A | 8,556 | $102.26 | $874,937 | 176,351 Direct | +5.10% | Acquired | -15.5% (price as of 2026-10-02) |
| March 30, 2015 | TPR | A | 33 | $41.44 | $1,368 | 1,884 Direct | +1.78% | Acquired | 185.0% (price as of 2026-10-02) |
| Feb. 27, 2015 | CVS | A | 18,051 | $103.87 | $1,874,957 | 104,968 Direct | +20.77% | Acquired | -16.8% (price as of 2026-10-02) |
| Dec. 29, 2014 | TPR | A | 36 | $37.49 | $1,350 | 1,851 Direct | +1.98% | Acquired | 215.1% (price as of 2026-10-02) |
Showing latest 100 of 165 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 1, 2026 | NKE | Non-Qualified Stock Option (Right to Buy) | Class B Common Stock | $38.12 | Sept. 1, 2036 | 259,946 | Acquired |
| Aug. 3, 2026 | HONA | Restricted Stock Units | Common Stock | · | · | 572 | Acquired |
| June 29, 2026 | HONA | Deferred Compensation (Phantom Shares) | Common Stock | · | · | 135 | Acquired |
| March 3, 2026 | PFE | Stock Appreciation Rights | Common Stock | $26.58 | March 3, 2031 | 216,537 | Acquired |
| March 4, 2025 | PFE | Stock Appreciation Rights | Common Stock | $25.75 | March 4, 2030 | 413,138 | Acquired |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock | $42.30 | Feb. 23, 2028 | 103,320 | Disposed |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock | $42.30 | Feb. 23, 2030 | 103,320 | Acquired |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock | $53.04 | May 31, 2027 | 80,703 | Disposed |
| Sept. 12, 2024 | PFE | Stock Appreciation Rights | Common Stock | $53.04 | May 31, 2029 | 80,703 | Acquired |
| Feb. 27, 2024 | PFE | Stock Appreciation Rights | Common Stock | $26.89 | Feb. 27, 2029 | 161,160 | Acquired |
| Feb. 27, 2024 | PFE | Stock Appreciation Rights | Common Stock | $26.89 | Feb. 27, 2031 | 142,400 | Acquired |
| Feb. 23, 2023 | PFE | Stock Appreciation Rights | Common Stock | $42.30 | Feb. 23, 2028 | 103,320 | Acquired |
| Feb. 23, 2023 | PFE | Stock Appreciation Rights | Common Stock | $42.30 | Feb. 23, 2030 | 89,920 | Acquired |
| Nov. 15, 2022 | TPR | Stock Option [F2] | Common Stock | $34.98 | Nov. 15, 2032 | 6,822 | Acquired |
| May 31, 2022 | PFE | Stock Appreciation Rights | Common Stock | $53.04 | May 31, 2027 | 80,703 | Acquired |
| May 31, 2022 | PFE | Stock Appreciation Rights | Common Stock | $53.04 | May 31, 2029 | 70,313 | Acquired |
| April 1, 2022 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock | $202.40 | April 1, 2032 | 18,265 | Acquired |
| April 1, 2022 | LOW | Performance Share Units | Common Stock | · | · | 38,220 | Disposed |
| March 17, 2022 | LOW | Performance Share Units | Common Stock | · | · | 38,220 | Acquired |
| Nov. 3, 2021 | TPR | Stock Option [F2] | Common Stock | $41.82 | Nov. 3, 2031 | 5,523 | Acquired |
| April 1, 2021 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock | $191.32 | April 1, 2031 | 21,593 | Acquired |
| Nov. 5, 2020 | TPR | Stock Option [F2] | Common Stock | $24.71 | Nov. 5, 2030 | 7,282 | Acquired |
| April 1, 2020 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock | $80.42 | April 1, 2030 | 57,141 | Acquired |
| Nov. 7, 2019 | TPR | Stock Option [F2] | Common Stock | $27.07 | Nov. 7, 2029 | 13,069 | Acquired |
| April 1, 2019 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock | $108.93 | April 1, 2029 | 41,900 | Acquired |
| Jan. 2, 2019 | LOW | Non-Qualified Stock Option (right to buy) | Common Stock | $92.27 | Jan. 2, 2029 | 40,700 | Acquired |
| Nov. 8, 2018 | TPR | Stock Option [F2] | Common Stock | $43.03 | Nov. 8, 2028 | 7,712 | Acquired |
| April 1, 2018 | CVS | Stock Option | Common Stock | $62.21 | April 1, 2025 | 116,767 | Acquired |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock | $78.05 | April 3, 2024 | 10,869 | Disposed |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock | $104.82 | April 1, 2023 | 22,716 | Disposed |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock | $102.26 | April 1, 2022 | 25,540 | Disposed |
| Feb. 20, 2018 | CVS | Stock Option | Common Stock | $74.29 | April 1, 2021 | 30,325 | Disposed |
| Nov. 9, 2017 | TPR | Stock Option [F2] | Common Stock | $40.16 | Nov. 9, 2027 | 9,338 | Acquired |
| Sept. 11, 2017 | CVS | Stock Option | Common Stock | $54.53 | April 1, 2020 | 108,183 | Disposed |
| June 12, 2017 | CVS | Stock Option | Common Stock | $34.96 | April 1, 2018 | 107,178 | Disposed |
| June 12, 2017 | CVS | Stock Option | Common Stock | $45.07 | April 2, 2019 | 110,912 | Disposed |
| June 12, 2017 | CVS | Stock Option | Common Stock | $40.28 | March 5, 2018 | 12,420 | Disposed |
| April 3, 2017 | CVS | Stock Option | Common Stock | $78.05 | April 3, 2024 | 100,179 | Acquired |
| March 10, 2017 | CVS | Stock Option | Common Stock | $36.23 | April 1, 2017 | 95,618 | Disposed |
| Nov. 10, 2016 | TPR | Stock Option [F2] | Common Stock | · | Nov. 10, 2026 | 11,284 | Acquired |
| April 1, 2016 | CVS | Stock Option | Common Stock | $104.82 | April 1, 2023 | 71,696 | Acquired |
| Nov. 4, 2015 | TPR | Stock Option [F2] | Common Stock | · | Nov. 4, 2025 | 11,734 | Acquired |
| Nov. 4, 2015 | TPR | Restricted Stock Unit | Common Stock | · | · | 2,330 | Disposed |
| Nov. 4, 2015 | TPR | Restricted Stock Unit [F2] | Common Stock | · | · | 2,323 | Acquired |
| Sept. 28, 2015 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 28 | Acquired |
| June 29, 2015 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 22 | Acquired |
| May 9, 2015 | TPR | Restricted Stock Unit | Common Stock | · | · | 1,847 | Disposed |
| April 1, 2015 | CVS | Stock Option | Common Stock | $102.26 | April 1, 2022 | 59,922 | Acquired |
| March 30, 2015 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 33 | Acquired |
| Dec. 29, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 36 | Acquired |
| Nov. 6, 2014 | TPR | Stock Option [F1] | Common Stock | · | Nov. 6, 2024 | 11,321 | Acquired |
| Nov. 6, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 2,241 | Acquired |
| Sept. 29, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 16 | Acquired |
| July 1, 2014 | CVS | Stock Option | Common Stock | $28.10 | April 1, 2016 | 48,178 | Disposed |
| July 1, 2014 | CVS | Stock Option | Common Stock | $41.17 | April 1, 2015 | 26,811 | Disposed |
| June 30, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 18 | Acquired |
| May 9, 2014 | TPR | Stock Option [F1] | Common Stock | · | May 9, 2024 | 9,226 | Acquired |
| May 9, 2014 | TPR | Restricted Stock Unit [F1] | Common Stock | · | · | 1,781 | Acquired |
| April 1, 2014 | CVS | Stock Option | Common Stock | $74.29 | April 1, 2021 | 62,943 | Acquired |
| Jan. 3, 2014 | CVS | Stock Option | Common Stock | $34.42 | April 2, 2014 | 14,113 | Disposed |
| April 1, 2013 | CVS | Stock Option | Common Stock | $54.53 | April 1, 2020 | 108,183 | Acquired |
| Sept. 13, 2012 | CVS | Stock Option | Common Stock | $30.04 | April 3, 2013 | 11,526 | Disposed |
| Sept. 13, 2012 | CVS | Stock Option | Common Stock | $30.04 | April 3, 2013 | 11,526 | Acquired |
| April 2, 2012 | CVS | Stock Option | Common Stock | $45.07 | April 2, 2019 | 110,912 | Acquired |
| Sept. 14, 2011 | CVS | Stock Option | Common Stock | $22.44 | Jan. 5, 2012 | 5,334 | Disposed |
| April 1, 2011 | CVS | Stock Option | Common Stock | $34.96 | April 1, 2018 | 107,178 | Acquired |
| March 4, 2011 | CVS | Stock Option | Common Stock | $30.26 | March 7, 2011 | 5,000 | Disposed |
| April 1, 2010 | CVS | Stock Option | Common Stock | $36.23 | April 1, 2017 | 95,618 | Acquired |
| April 1, 2009 | CVS | Stock Option | Common Stock | $28.10 | April 1, 2016 | 48,178 | Acquired |
| April 1, 2008 | CVS | Stock Option | Common Stock | $41.17 | April 1, 2015 | 26,811 | Acquired |
| March 5, 2008 | CVS | Stock Option | Common Stock | $40.28 | March 5, 2018 | 12,420 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 9, 2022 | PFE | Common Stock | 890 | Direct |
| March 7, 2008 | CVS | Common Stock | 11,127 | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | · | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | · | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | · | Direct |
| March 7, 2008 | CVS | Common Stock (Restricted) | · | Direct |
| March 7, 2008 | CVS | Common Stock | 297 | Indirect |
| March 7, 2008 | CVS | Stock Option | 5,334 | Direct |
| March 7, 2008 | CVS | Stock Option | 11,526 | Direct |
| March 7, 2008 | CVS | Stock Option | 5,000 | Direct |
| March 7, 2008 | CVS | Stock Option | 14,113 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $959,856 | · | · | · | $2,276,778 | · | $12,556 | $7,779,201 |
| 2020 | $941,010 | · | · | · | $2,352,524 | · | $12,000 | $10,812,068 |
| 2019 | $925,000 | · | · | · | $501,840 | · | $39,092 | $5,777,182 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $825,000 | · | · | · | $3,975,043 | · | · | $14,684,580 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.